FDA OKs Marketing of First AI Device Used to Detect Lesions During Colonoscopy

MONDAY, April 12, 2021 -- The U.S. Food and Drug Administration cleared the way for marketing of the first device to use artificial intelligence based on machine learning to help detect lesions during colonoscopy, the agency announced Friday. The...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news